Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, Neil Bretana, Gregory J Dore, Louisa Degenhardt, Sarah Larney, Fabio Luciani, Andrew R Lloyd, Jason Grebely
International Journal of Drug Policy | ELSEVIER SCIENCE BV | Published : 2018
BACKGROUND: HCV transmission remains high in prisons globally. Understanding injecting risk behaviours in prisons is crucial to effectively develop and implement HCV prevention programs in this setting including treatment as prevention. METHODS: HITS-p is a cohort study which enrolled people with a history of injecting drug use in prisons in NSW, Australia from 2005 to 2013. Participants completed an interview at enrolment and follow-up visits to determine injecting behaviours. Generalized estimating equation (GEE) and logistic regression methods were used to assess injecting risk behaviours prior to and following prison entry and to investigate injecting risk behaviours in prison. RESULTS: ..View full abstract
Awarded by NHMRC
Awarded by National Health and Medical Research Council
The Kirby Institute is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, UNSW. Sydney. The views expressed in this publication do not necessarily represent the position of the Australian Government. The HITS-p investigators include: Andrew Lloyd, Kate Dolan, Paul Haber, William Rawlinson, Carla Treloar, Greg Dore, Lisa Maher, and Fabio Luciani. The HITS-p cohort has been supported by grants from NHMRC (Nos. 222887 and 1016351) including NSW Health, Justice Health, and Corrective Services NSW as partners. EBC is supported by a scholarship from the Canadian Network on Hepatitis C. AL is supported by a National Health and Medical Research Council Practitioner Fellowship (No. 1043067). GJD is supported through National Health and Medical Research Council of Australia Practitioner Fellowship. JG is supported by a National Health and Medical Research Council Career Development Fellowship. BH is supported by a National Health and Medical Research Council Early Career Fellowship.